BioCentury
ARTICLE | Financial News

PolyPid sets IPO terms

November 1, 2014 1:01 AM UTC

PolyPid Ltd. (Petach Tikva, Israel) amended its proposed IPO on NASDAQ and now plans to sell 1.8 million shares at $10-$12. At $11, PolyPid would raise $20 million and be valued at $103 million. Aegis Capital; MLV; and Chardan are underwriters. ...